RhumbLine Advisers’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $290K | Sell |
17,569
-298,497
| -94% | -$4.92M | ﹤0.01% | 3093 |
|
|
2026
Q1 | $5.15M | Buy |
316,066
+3,647
| +1% | +$57.1K | ﹤0.01% | 1390 |
|
|
2025
Q4 | $4.64M | Sell |
312,419
-21,015
| -6% | -$297K | ﹤0.01% | 1439 |
|
|
2025
Q3 | $4.28M | Buy |
333,434
+6,882
| +2% | +$91.7K | ﹤0.01% | 1513 |
|
|
2025
Q2 | $4.96M | Buy |
326,552
+14,186
| +5% | +$221K | ﹤0.01% | 1418 |
|
|
2025
Q1 | $5.22M | Sell |
312,366
-4,136
| -1% | -$76.1K | ﹤0.01% | 1338 |
|
|
2024
Q4 | $5.97M | Sell |
316,502
-269,747
| -46% | -$5.2M | 0.01% | 1334 |
|
|
2024
Q3 | $11M | Sell |
586,249
-20,979
| -3% | -$402K | 0.01% | 1008 |
|
|
2024
Q2 | $11.5M | Buy |
607,228
+15,209
| +3% | +$259K | 0.01% | 964 |
|
|
2024
Q1 | $9.62M | Buy |
592,019
+1,859
| +0.3% | +$27.2K | 0.01% | 1062 |
|
|
2023
Q4 | $7.47M | Sell |
590,160
-3,096
| -0.5% | -$39.1K | 0.01% | 1195 |
|
|
2023
Q3 | $8.08M | Buy |
593,256
+5,431
| +0.9% | +$83.9K | 0.01% | 1091 |
|
|
2023
Q2 | $10.1M | Sell |
587,825
-22,077
| -4% | -$342K | 0.01% | 1006 |
|
|
2023
Q1 | $8.49M | Buy |
609,902
+30,533
| +5% | +$449K | 0.01% | 1037 |
|
|
2022
Q4 | $7.75M | Buy |
579,369
+8,025
| +1% | +$104K | 0.01% | 1055 |
|
|
2022
Q3 | $6.8M | Buy |
571,344
+21,677
| +4% | +$308K | 0.01% | 1086 |
|
|
2022
Q2 | $7M | Buy |
549,667
+21,509
| +4% | +$276K | 0.01% | 1081 |
|
|
2022
Q1 | $6.83M | Buy |
528,158
+32,966
| +7% | +$435K | 0.01% | 1136 |
|
|
2021
Q4 | $7.84M | Buy |
495,192
+2,650
| +0.5% | +$45.2K | 0.01% | 1120 |
|
|
2021
Q3 | $9.6M | Sell |
492,542
-83,657
| -15% | -$1.66M | 0.01% | 978 |
|
|
2021
Q2 | $13.1M | Sell |
576,199
-8,903
| -2% | -$185K | 0.02% | 848 |
|
|
2021
Q1 | $10.8M | Buy |
585,102
+2,047
| +0.4% | +$33.6K | 0.01% | 947 |
|
|
2020
Q4 | $8.69M | Buy |
583,055
+12,174
| +2% | +$159K | 0.01% | 1014 |
|
|
2020
Q3 | $6.4M | Sell |
570,881
-52,828
| -8% | -$520K | 0.01% | 1007 |
|
|
2020
Q2 | $4.95M | Sell |
623,709
-52,222
| -8% | -$433K | 0.01% | 1224 |
|
|
2020
Q1 | $5.46M | Buy |
675,931
+21,160
| +3% | +$251K | 0.01% | 973 |
|
|
2019
Q4 | $8.23M | Buy |
654,771
+36,871
| +6% | +$397K | 0.01% | 956 |
|
|
2019
Q3 | $5.52M | Buy |
617,900
+18,186
| +3% | +$159K | 0.01% | 1138 |
|
|
2019
Q2 | $5.13M | Buy |
599,714
+29,647
| +5% | +$234K | 0.01% | 1183 |
|
|
2019
Q1 | $4.33M | Buy |
570,067
+873
| +0.2% | +$7.02K | 0.01% | 1262 |
|
|
2018
Q4 | $4.71M | Buy |
569,194
+102,752
| +22% | +$983K | 0.01% | 1141 |
|
|
2018
Q3 | $4.62M | Sell |
466,442
-12,423
| -3% | -$129K | 0.01% | 1164 |
|
|
2018
Q2 | $4.68M | Buy |
478,865
+19,021
| +4% | +$187K | 0.01% | 1138 |
|
|
2018
Q1 | $4.27M | Buy |
459,844
+9,025
| +2% | +$85.9K | 0.01% | 1142 |
|
|
2017
Q4 | $4.29M | Buy |
450,819
+58,926
| +15% | +$563K | 0.01% | 1165 |
|
|
2017
Q3 | $4.05M | Buy |
391,893
+4,394
| +1% | +$40.6K | 0.01% | 1163 |
|
|
2017
Q2 | $3.21M | Sell |
387,499
-18,614
| -5% | -$140K | 0.01% | 1278 |
|
|
2017
Q1 | $2.92M | Buy |
406,113
+119,584
| +42% | +$867K | 0.01% | 1335 |
|
|
2016
Q4 | $2.05M | Sell |
286,529
-10,982
| -4% | -$76.4K | 0.01% | 1436 |
|
|
2016
Q3 | $2.16M | Buy |
297,511
+13,632
| +5% | +$86.6K | 0.01% | 1350 |
|
|
2016
Q2 | $1.66M | Buy |
283,879
+48,857
| +21% | +$324K | ﹤0.01% | 1467 |
|
|
2016
Q1 | $1.5M | Buy |
235,022
+8,900
| +4% | +$47.7K | ﹤0.01% | 1563 |
|
|
2015
Q4 | $1.45M | Buy |
226,122
+19,228
| +9% | +$120K | ﹤0.01% | 1556 |
|
|
2015
Q3 | $1.2M | Buy |
206,894
+9,063
| +5% | +$67.2K | ﹤0.01% | 1659 |
|
|
2015
Q2 | $1.73M | Buy |
197,831
+31,784
| +19% | +$267K | 0.01% | 1513 |
|
|
2015
Q1 | $1.33M | Buy |
166,047
+51,365
| +45% | +$384K | ﹤0.01% | 1682 |
|
|
2014
Q4 | $890K | Sell |
114,682
-3,425
| -3% | -$25K | ﹤0.01% | 1889 |
|
|
2014
Q3 | $766K | Sell |
118,107
-185
| -0.2% | -$1.43K | ﹤0.01% | 1931 |
|
|
2014
Q2 | $994K | Buy |
118,292
+3,554
| +3% | +$27.6K | ﹤0.01% | 1822 |
|
|
2014
Q1 | $770K | Sell |
114,738
-4,029
| -3% | -$24.4K | ﹤0.01% | 1971 |
|
|
2013
Q4 | $743K | Sell |
118,767
-11,571
| -9% | -$56.5K | ﹤0.01% | 2009 |
|
|
2013
Q3 | $567K | Sell |
130,338
-3,613
| -3% | -$16.5K | ﹤0.01% | 2134 |
|
|
2013
Q2 | $592K | Buy |
+133,951
| New | +$593K | ﹤0.01% | 2134 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
RhumbLine Advisers's SEM Position: Q2 2026 in Review
RhumbLine Advisers reduced its Select Medical (SEM) stake by 94% in Q2 2026, selling an estimated $4.92M and leaving 17,569 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3093.
RhumbLine Advisers first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.1M in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- RhumbLine Advisers held 17,569 shares of Select Medical worth $290K as of Q2 2026.
- RhumbLine Advisers sold 298,497 Select Medical shares in Q2 2026, an estimated $4.92M.
- Select Medical made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3093 holding.
- RhumbLine Advisers first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Select Medical position peaked at $13.1M in Q2 2021.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.